Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Paroxysmal Nocturnal Hemoglobinuria Treatment

• 1.1 Definition of Paroxysmal Nocturnal Hemoglobinuria Treatment
• 1.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment by Type
  • 1.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ACH-4471
  • 1.2.3 ALN-CC5
  • 1.2.4 ALXN-1210
  • 1.2.5 AMY-101
  • 1.2.6 APL-2
  • 1.2.7 Others
• 1.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment by Applications
  • 1.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Overall Market
  • 1.4.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (2014-2025)
  • 1.4.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production (2014-2025)
  • 1.4.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment
• 2.3 Manufacturing Process Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment
• 2.4 Industry Chain Structure of Paroxysmal Nocturnal Hemoglobinuria Treatment

3 Development and Manufacturing Plants Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Paroxysmal Nocturnal Hemoglobinuria Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Production and Capacity Analysis
• 4.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Analysis
• 4.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Paroxysmal Nocturnal Hemoglobinuria Treatment Regional Market Analysis

• 5.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Production by Regions
  • 5.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production by Regions
  • 5.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Regions
• 5.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption by Regions
• 5.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
  • 5.3.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Production
  • 5.3.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
• 5.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
  • 5.4.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Production
  • 5.4.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
• 5.5 China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
  • 5.5.1 China Paroxysmal Nocturnal Hemoglobinuria Treatment Production
  • 5.5.2 China Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
• 5.6 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
  • 5.6.1 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Production
  • 5.6.2 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
• 5.7 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
  • 5.7.1 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Production
  • 5.7.2 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
• 5.8 India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
  • 5.8.1 India Paroxysmal Nocturnal Hemoglobinuria Treatment Production
  • 5.8.2 India Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export

6 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment Market Analysis (by Type)

• 6.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production by Type
• 6.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Type
• 6.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Price by Type

7 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment Market Analysis (by Application)

• 7.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption by Application
• 7.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption Market Share by Application (2014-2019)

8 Paroxysmal Nocturnal Hemoglobinuria Treatment Major Manufacturers Analysis

• 8.1 Achillion Pharmaceuticals Inc
  • 8.1.1 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.1.2 Achillion Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.1.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Akari Therapeutics Plc
  • 8.2.1 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.2.2 Akari Therapeutics Plc Product Introduction, Application and Specification
  • 8.2.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Alexion Pharmaceuticals Inc
  • 8.3.1 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.3.2 Alexion Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.3.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Alnylam Pharmaceuticals Inc
  • 8.4.1 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.4.2 Alnylam Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.4.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Amgen Inc
  • 8.5.1 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.5.2 Amgen Inc Product Introduction, Application and Specification
  • 8.5.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Apellis Pharmaceuticals Inc
  • 8.6.1 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.6.2 Apellis Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.6.3 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 F. Hoffmann-La Roche Ltd
  • 8.7.1 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.7.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
  • 8.7.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 ISU ABXIS Co Ltd
  • 8.8.1 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.8.2 ISU ABXIS Co Ltd Product Introduction, Application and Specification
  • 8.8.3 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Novartis AG
  • 8.9.1 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.9.2 Novartis AG Product Introduction, Application and Specification
  • 8.9.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 NovelMed Therapeutics Inc
  • 8.10.1 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
  • 8.10.2 NovelMed Therapeutics Inc Product Introduction, Application and Specification
  • 8.10.3 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Omeros Corp
• 8.12 Ra Pharmaceuticals Inc
• 8.13 Regeneron Pharmaceuticals Inc
• 8.14 Regenesance BV

9 Development Trend of Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment Market

• 9.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trend Analysis
  • 9.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Regional Market Trend
  • 9.2.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
  • 9.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
  • 9.2.3 China Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
  • 9.2.4 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
  • 9.2.6 India Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
• 9.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trend (Product Type)
• 9.4 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List